Protocol Design Services & Products
-
End-To-End Ophthalmic Drug Development Solutions
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Develop And Implement Effective Brand Strategies
12/6/2023
Insights to guide your decision-making, from strategic planning to launch optimization and beyond.
-
Enhance Data Quality, Increase Efficiency, And Drive Innovation
12/6/2023
Technology to meet the demands of today's clinical research and drug safety, ensuring innovation is at the forefront in clinical trial execution.
-
Strategic Support for Preclinical And Early Phase Planning
12/6/2023
Data, tools, and guidance to identify and prioritize opportunities and optimize clinical trial planning.
-
Clinical And Regulatory Strategy
11/7/2023
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
Cell & Gene Therapy Solutions
9/29/2023
Your therapy can make all the difference. Together, we’ll unlock its potential.
-
Get Novel Infectious Disease Vaccines, Therapies To Market Faster
9/20/2023
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
Making The Impossible Possible In Oncology And Hematology Clinical Development
9/20/2023
When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
-
Bringing Endocrine And Metabolic Disease Treatments To Market
9/20/2023
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
Driving Successful In CNS And Neurology Trials
9/20/2023
Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.